Leber先天性黑矇
Leber congenital amaurosis
定义 英文原文(暂无中文)
Leber congenital amaurosis (LCA) is a retinal dystrophy defined by blindness and responses to electrophysiological stimulation (Ganzfeld electroretinogram (ERG)) below threshold, associated with severe visual impairment within the first year of life.
别名
Leber先天性黒矇
基本事实
- 遗传方式
- 常染色体显性、常染色体隐性
- 发病年龄
- 婴儿期、新生儿期
- 患病率
- 1-9 / 100 000(Europe)
相关基因 26
| 基因 | 名称 | 关联类型 |
|---|---|---|
| PRPH2 | peripherin 2 | Disease-causing germline mutation(s) in |
| RD3 | RD3 regulator of GUCY2D | Disease-causing germline mutation(s) in |
| RDH12 | retinol dehydrogenase 12 | Disease-causing germline mutation(s) (loss of function) in |
| RPE65 | retinoid isomerohydrolase RPE65 | Disease-causing germline mutation(s) in |
| RPGRIP1 | RPGR interacting protein 1 | Disease-causing germline mutation(s) (loss of function) in |
| CABP4 | calcium binding protein 4 | Disease-causing germline mutation(s) in |
| CEP290 | centrosomal protein 290 | Disease-causing germline mutation(s) in |
| AIPL1 | AIP like 1 HSP90 co-chaperone | Disease-causing germline mutation(s) in |
| ALMS1 | ALMS1 centrosome and basal body associated protein | Disease-causing germline mutation(s) in |
| TULP1 | TUB like protein 1 | Disease-causing germline mutation(s) in |
| CRB1 | crumbs cell polarity complex component 1 | Disease-causing germline mutation(s) in |
| CRX | cone-rod homeobox | Disease-causing germline mutation(s) in |
| GUCY2D | guanylate cyclase 2D, retinal | Disease-causing germline mutation(s) (loss of function) in |
| IMPDH1 | inosine monophosphate dehydrogenase 1 | Disease-causing germline mutation(s) in |
| IQCB1 | IQ motif containing B1 | Disease-causing germline mutation(s) (loss of function) in |
| OTX2 | orthodenticle homeobox 2 | Disease-causing germline mutation(s) in |
| LCA5 | lebercilin LCA5 | Disease-causing germline mutation(s) in |
| KCNJ13 | potassium inwardly rectifying channel subfamily J member 13 | Disease-causing germline mutation(s) in |
| LRAT | lecithin retinol acyltransferase | Disease-causing germline mutation(s) in |
| SPATA7 | spermatogenesis associated 7 | Disease-causing germline mutation(s) in |
| GDF6 | growth differentiation factor 6 | Disease-causing germline mutation(s) in |
| IFT140 | intraflagellar transport 140 | Disease-causing germline mutation(s) in |
| NMNAT1 | nicotinamide nucleotide adenylyltransferase 1 | Disease-causing germline mutation(s) in |
| PCYT1A | phosphate cytidylyltransferase 1A, choline | Disease-causing germline mutation(s) (loss of function) in |
| USP45 | ubiquitin specific peptidase 45 | Disease-causing germline mutation(s) in |
| TUBB4B | tubulin beta 4B class IVb | Disease-causing germline mutation(s) in |
临床表型 25
极常见 99–80%3
- 视网膜色素异常 HP:0007703
- 视盘形态异常 HP:0012795
- 视力严重下降 HP:0001141
常见 79–30%15
- 视网膜电图异常 HP:0000512
- 全视野视网膜电图异常 HP:0030466
- 神经细胞迁移异常 HP:0002269
- 小脑蚓部发育缺陷/发育不全 HP:0006817
- 白内障 HP:0000518
- 脑膨出 HP:0002084
- 戳眼 HP:0001483
- 偏瘫/轻偏瘫 HP:0004374
- 远视 HP:0000540
- 肌张力减退 HP:0001252
- 圆锥角膜 HP:0000563
- 眼球震颤 HP:0000639
- 畏光 HP:0000613
- 癫痫发作 HP:0001250
- 瞳孔对光反应缓慢 HP:0030211
偶见 29–5%7
- 自闭症行为 HP:0000729
- 全面发育迟缓 HP:0001263
- 听力受损 HP:0000365
- 智力障碍 HP:0001249
- 运动发育迟缓 HP:0001270
- 视盘玻璃疣 HP:0012426
- 视盘苍白 HP:0000543
近两年的全球研究 852L2
2024/08 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。
- 2026-07Breakpoint-level characterization of a novel CEP290 tandem duplication in trans with a pathogenic splice-site variant in a patient with Leber congenital amaurosis
- 2026-07AI-engineered AAV capsid enables intravitreal delivery for the treatment of diverse retinal degenerations
- 2026-06Clinical and genetic characteristics of RPE65-associated inherited retinal degeneration in Koreans
- 2026-06综述Programmed axon degeneration gene variants in human disease
- 2026-06Ora visual navigation course™ mobility test results in two individuals with <i>CEP290</i> LCA after intravitreal injection of antisense oligonucleotide
- 2026-06Absent cone function and stable ophthalmic features in a non-syndromic woman with pathogenic variants in <i>CEP290</i>
- 2026-06综述Trends in the Engineering of Adeno-Associated Virus (AAV) for Precision Gene Delivery to the Central Nervous System (CNS)
- 2026-06Personalized Pathogenicity Assessment of <i>RPE65</i> Gene Mutations Using Patient-Specific hiPSC-Derived Retinal Pigment Epithelium Model
- 2026-06Screening for RPE65 genetic variants in Egyptian children with inherited retinal disorders: a study from a tertiary eye care center in Egypt
- 2026-06系统综述开放获取A systematic review of neuroprotective therapies for visual acuity preservation in retinitis pigmentosa
- 2026-06病例报告开放获取Coats-like exudative vasculopathy in a patient with Bardet-Biedl syndrome
- 2026-06综述Therapeutic applications of gene editing using CRISPR-Cas9 in the posterior segment: review of the literature
- 2026-06病例报告The co-occurrence of homozygous variants in GUCY2D and MYO7A in Leber congenital amaurosis associated with deafness: clinical, molecular, and in silico investigation
- 2026-06开放获取A homozygous CTLA-4 variant causes CTLA-4 deficiency with severe immune dysregulation
- 2026-06开放获取Engineered tRNA reduces vision loss in a mouse model of Leber congenital amaurosis
- 2026-06综述Revisiting retinal and macular degeneration in the genomics era
- 2026-06综述Pathogenicity Analysis of Two Novel CRB1 Mutations in Three Chinese Inherited Retinal Dystrophy Families and a Literature Review
- 2026-06开放获取Swiss cheese Is Essential for Maintaining Spermatogenesis and the Proper Functioning of Biological Barriers in Drosophila
- 2026-06开放获取Streamlined synthetic regulatory cassette for efficient and photoreceptor-enriched retinal gene expression
- 2026-06开放获取DELETION INVOLVING EXON 18 OF RPGRIP1 IS a MAJOR CAUSE OF ACHROMATOPSIA
境外已获批用于本病的药物 1L2
欧盟 1 项、美国 0 项。同一药物在两地各批一次的,会分别列出。
「境外已获批」不等于「在中国能用」。中间隔着进口注册、临床急需境外新药通道、海南博鳌乐城国际医疗旅游先行区等几条路径,各有各的条件与费用。这一节能确定地告诉你的只有一件事:这个病在世界范围内已经有获得批准的药物,它叫什么名字。拿这个名字去问主治医生,是下一步最省力的做法。
药名一律保留英文原文,不作翻译——中国的药品通用名与英文名的音译经常不一致,译错会让人去找一个不存在的药。
- Luxturna欧盟2018-11-22voretigene neparvovec官方记录
已获孤儿药资格、尚未获批的在研药物(5 项)
孤儿药资格只是一种监管身份——它意味着监管机构认可这是罕见病用药并给予研发激励,不代表这个药已被证明有效,也不代表将来一定能上市。绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。
- Recombinant adeno-associated virus retinal pigment epithelium gene vec美国2008-06-24Treatment of Leber congenital amaurosis due to RPE65 mutations.官方记录
- adenovirus associated viral vector serotype 5 containing the human RPE美国2016-03-10Treatment of Leber congenital amaurosis官方记录
- adenovirus associated viral vector serotype 8 containing the human AIP美国2018-02-01Treatment of inherited retinal dystrophy due to defects in AIPL1 gene, including Leber congenital amaurosis, retinitis pigmentosa, and cone-rod dystrophy官方记录
- Human Nuclear Hormone Receptor Subfamily 2 Group E Member 3 (hNR2E3)美国2022-12-15Treatment of Leber congenital amaurosis官方记录
- adeno-associated virus serotype 8 vector containing single-stranded DN美国2024-09-18treatment of retinal dystrophy due to mutations in the lebercilin gene, including Leber congenital amaurosis官方记录
数据来自欧洲药品管理局(EMA)的药品与孤儿药资格公开导出表,以及美国 FDA 孤儿药资格数据库。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。
在中国开展的临床试验 3L2
按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实,并与主治医生商量。
登记为可入组 1
- 招募中NCT05906953Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR)中国研究中心 1 个:Shanghai
其他状态的试验(2 项)
- 状态未知NCT03566147Treatment of RP and LCA by Primary RPE Transplantation中国研究中心 1 个:Beijing
- 进行中·不再招募NCT06088992Leber Congenital Amaurosis Inherited Blindness of Gene Therapy Trial(LIGHT)中国研究中心 1 个:Shanghai
中国境外的在招试验 6L2
这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。
CT.gov 报告命中 6 项,此处取回并展示最近的 5 项。
- 尚未开始招募NCT07681778Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)美国
- 招募中NCT06891443Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)比利时、巴西、加拿大、法国、德国、荷兰、西班牙、英国 等 9 国
- 尚未开始招募NCT06024057An Expanded Clinical Study Evaluating the AAV2-RPE65 Gene Therapy(LX101) in Patients With LCA
- 招募中NCT02435940Inherited Retinal Degenerative Disease Registry美国
- 招募中NCT01793168Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford澳大利亚、美国
外部标识与链接
发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
- 中文病名:Orphanet 中文包,冻结于 2020-06-01
- 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)